Antibody Drug Conjugates (ADC) Market To Hit USD 29.10 Billion By 2032, Driven By Rising Cancer Cases
Antibody Drug Conjugates Market Market Growth Fueled by Advancements in ADC Technology, Increased Demand for Targeted Cancer Therapies, and ...
BioSpace12h
The Top 7 Biopharma Licensing Deals of 2024
Faced with the encroaching threats of patent expirations and generics, biopharma companies in 2024 invested 33% more in ...
Bristol Myers Squibb Co. stock underperforms Tuesday when compared to competitors
Bristol Myers Squibb Co. closed 3.24% short of its 52-week high of $61.10, which the company reached on January 27th.
Taiwan News21h
Asia Pacific Biopharmaceuticals Market Surviving the Shift Future-Proofing Your Business with Market Size Insights
Request To Download Free Sample of This Strategic Report @ Highlighted with 41 tables and 85 figures, this 159-page report ?Asia Pacific Biopharmaceuticals Market 2023-2033 by Product Type, Testing ...
Taiwan News21h
North America Biopharmaceuticals Market Narratives of Choice Ethnography Techniques and Consumer Insights
Request To Download Free Sample of This Strategic Report @ Highlighted with 36 tables and 83 figures, this 153-page report ?North America Biopharmaceuticals Market 2023-2033 by Product Type, Testing ...
FiercePharma23h
Bristol Myers Squibb, Kyowa Kirin layoffs hit 119 in New Jersey amid separate restructuring campaigns
As the major cost-cutting initiative at Bristol Myers Squibb rolls on, the company has launched another round of layoffs in ...
Bristol-Myers Squibb's SWOT analysis: stock outlook mixed amid pipeline progress
Bristol-Myers Squibb (NYSE:BMY), a global biopharmaceutical giant with a market capitalization of $120.8 billion, finds ...